Yale University retains prominent attorney to defend FOIA request made by Yale student Sarah Braasch

Sarah Braasch, made unintentionally famous by the “napping while black” incident at Yale University on May 8, 2018, made an FOIA request to the state of Connecticut in hopes that Yale Police Department would release body camera footage of the police interview with Sarah herself only.

Sarah contends that what she said during this interview was not racist in nature, but instead was an attempt to explain the backstory of the situation. She believes the release of the footage will exonerate her of the statements rapidly made by Yale University couching the incident in racist terminology.

The hearing was scheduled for October 3, 2019, but the new attorney had requested a postponement and this postponement has been granted by the State of Connecticut. Braasch had already booked and paid for her travel.

The request for the postponement was made by Aaron Bayer, partner in the law firm Wiggin and Dana. According to Mr. Bayer’s impressive bio, he is “a litigation partner who heads the firm’s Education Practice Group and previously chaired the firm’s Appellate Practice Group.” His complete bio may be found here. https://www.wiggin.com/content/uploads/pdf/aaron-s-bayer.pdf

Mr. Bayer “draws on his experience in positions in higher education and government to advise colleges, universities, private secondary schools, and nonprofit organizations on the complex legal, regulatory, and public relations issues they regularly face.”

What is FOIA? Courtesty United States Government, FOIA.gov

Since 1967, the Freedom of Information Act (FOIA) has provided the public the right to request access to records from any federal agency. It is often described as the law that keeps citizens in the know about their government. Federal agencies are required to disclose any information requested under the FOIA unless it falls under one of nine exemptions which protect interests such as personal privacy, national security, and law enforcement.

The FOIA also requires agencies to proactively post online certain categories of information, including frequently requested records. As Congress, the President, and the Supreme Court have all recognized, the FOIA is a vital part of our democracy.

What is the Presumption of Openness and Who Issues Guidance to Agencies on the FOIA?

The FOIA provides that when processing requests, agencies should withhold information only if they reasonably foresee that disclosure would harm an interest protected by an exemption, or if disclosure is prohibited by law. Agencies should also consider whether partial disclosure of information is possible whenever they determine that full disclosure is not possible and they should take reasonable steps to segregate and release nonexempt information. The Office of Information Policy at the Department of Justice is responsible for issuing government-wide guidance on the FOIA as part of its responsibilities to encourage all agencies to fully comply with both the letter and the spirit of the FOIA.

COMPASS Pathways Receives FDA Approval for Psilocybin Therapy Clinical Trial for Treatment-resistant Depression

Illustrator: Gordon Robinson

COMPASS Pathways, a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health, has received approval from the US Food and Drug Administration (FDA) for a clinical trial in psilocybin therapy for treatment-resistant depression. Regulatory approvals for the trial have already been given in the UK, the Netherlands and Canada.

Magic mushrooms may ‘reset’ the brains of depressed patients: Imperial College London

The trial is a phase IIb dose-ranging study with 216 patients taking part in 12 to 15 research sites across Europe and North America. It will begin in the UK later this month and sites in other countries will join the trial as further regulatory approvals are received.

Psilocybin therapy combines a dose of psilocybin (a psychoactive medicine and the active ingredient in “magic mushrooms”) with psychological support, and has shown promising signals of efficacy and safety as treatment for depression in academic studies in the UK and US. If the trial is successful, it will be followed by phase III studies.

George Goldsmith, Chairman and Co-founder of COMPASS Pathways, said, “We are excited to be starting this landmark trial which has the potential to transform lives. Depression is the leading cause of ill-health and disability worldwide, and treatment-resistant depression affects more than 100 million people. It is a huge unmet need and the trial will teach us more about how this new approach might address it.”

Ekaterina Malievskaia, Chief Medical Officer and Co-founder of COMPASS, said: “The design of this study has been a truly collaborative effort, with scientists, clinicians, patient representatives and regulators from Europe and North Americaworking together with the goal of helping patients suffering with treatment-resistant depression.”

About COMPASS Pathways

COMPASS Pathways is a life sciences company, founded in 2016 to accelerate patient access to evidence-based innovation in mental health. We are developing psilocybin therapy through a late-stage clinical trial in Europe and North America for patients with treatment-resistant depression. We will improve mental health through the development of new patient care pathways, based on advances in neuroscience, psychotherapy, psychopharmacology, and technology.

http://www.compasspathways.com

SOURCE Compass Pathways

Roseanne Barr and Rabbi Shmuley Boteach Statement on Roseanne Cancellation and Conners Premiere

FOR IMMEDIATE RELEASE

ROSEANNE BARR AND RABBI SHMULEY BOTEACH STATEMENT ON ROSEANNE CANCELLATION AND CONNNERS PREMIERE

NEW YORK, NY; October 17, 2018 – Roseanne Barr and her longtime Rabbi and friend, World Values Network Founder Rabbi Shmuley Boteach, have issued the following statement regarding the cancellation of Roseanne and the premiere of The Conners:

“While we wish the very best for the cast and production crew of The Conners, all of whom are deeply dedicated to their craft and were Roseanne’s cherished colleagues, we regret that ABC chose to cancel Roseanne by killing off the Roseanne Conner character. That it was done through an opioid overdose lent an unnecessary grim and morbid dimension to an otherwise happy family show.

“This was a choice the network did not have to make. Roseanne was the only show on television that directly addressed the deep divisions threatening the very fabric of our society. Specifically, the show promoted the message that love and respect for one another’s personhood should transcend differences in background and ideological discord. The show brought together characters of different political persuasions and ethnic backgrounds in one, unified family, a rarity in modern American entertainment. Above all else, the show celebrated a strong, matriarchal woman in a leading role, something we need more of in our country.

“Through humor and a universally relatable main character, the show represented a weekly teaching moment for our nation. Yet it is often following an inexcusable — but not unforgivable — mistake that we can discover the most important lesson of all: Forgiveness. After repeated and heartfelt apologies, the network was unwilling to look past a regrettable mistake, thereby denying the twin American values of both repentance and forgiveness. In a hyper-partisan climate, people will sometimes make the mistake of speaking with words that do not truly reflect who they are. However, it is the power of forgiveness that defines our humanity.

“Our society needs to heal on many levels. What better way for healing than a shared moment, once a week, where we could have all enjoyed a compelling storyline featuring a witty character – a woman – who America connected with, not in spite of her flaws, but because of them. The cancellation of Roseanne is an opportunity squandered due in equal parts to fear, hubris, and a refusal to forgive.”

###
About The World Values Network
The World Values Network’s mission is to disseminate universal Jewish values in politics, culture, and media, making the Jewish people a light unto the nations.

It is our belief that Judaism, with its unique emphasis on perfecting the world and celebrating life, can benefit America against some the greatest challenges of our time including high rates of divorce, teen alienation, depression, and growing ignorance and materialism.
###

THE WORLD VALUES NETWORK www.worldvalues.us
RUBENSTEIN PUBLIC RELATIONS CONTACT: JOSH BERKMAN, 212-805-3055 JBERKMAN@RUBENSTEINPR.COM

New CDC analysis shows steep and sustained increases in STDs in recent years

Latest U.S. data reveal threat to multiple populations

Nearly 2.3 million cases of chlamydia, gonorrhea, and syphilis were diagnosed in the United States in 2017, according to preliminary data released today by the Centers for Disease Control and Prevention (CDC) at the National STD Prevention Conference in Washington, D.C. This surpassed the previous record set in 2016 by more than 200,000 cases and marked the fourth consecutive year of sharp increases in these sexually transmitted diseases (STDs).

The CDC analysis of STD cases reported for 2013 and preliminary data for 2017 shows steep, sustained increases:

Gonorrhea diagnoses increased 67 percent overall (from 333,004 to 555,608 cases according to preliminary 2017 data) and nearly doubled among men (from 169,130 to 322,169). Increases in diagnoses among women — and the speed with which they are increasing — are also concerning, with cases going up for the third year in a row (from 197,499 to 232,587).

Primary and secondary syphilis diagnoses increased 76 percent (from 17,375 to 30,644 cases). Gay, bisexual and other men who have sex with men (MSM) made up almost 70 percent of primary and secondary syphilis cases where the gender of the sex partner is known in 2017. Primary and secondary syphilis are the most infectious stages of the disease.

Chlamydia remained the most common condition reported to CDC. More than 1.7 million cases were diagnosed in 2017, with 45 percent among 15- to 24-year-old females.

“We are sliding backward,” said Jonathan Mermin, M.D., M.P.H, director of CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. “It is evident the systems that identify, treat, and ultimately prevent STDs are strained to near-breaking point.”

Chlamydia, gonorrhea, and syphilis are curable with antibiotics, yet most cases go undiagnosed and untreated — which can lead to severe adverse health effects that include infertility, ectopic pregnancy, stillbirth in infants, and increased HIV risk. Prior studies suggest a range of factors may contribute to STD increases, including socioeconomic factors like poverty, stigma, and discrimination; and drug use.

Continued concerns about antibiotic resistant gonorrhea

The threat of untreatable gonorrhea persists in the United States, and reports of antibiotic resistant gonorrhea abroad have only reinforced those concerns. Over the years, gonorrhea has become resistant to nearly every class of antibiotics used to treat it, except to ceftriaxone, the only remaining highly effective antibiotic to treat gonorrhea in the United States.

In 2015, CDC began recommending health care providers prescribe a single shot of ceftriaxone accompanied by an oral dose of azithromycin to people diagnosed with gonorrhea. Azithromycin was added to help delay the development of resistance to ceftriaxone.

Emerging resistance to ceftriaxone has not been seen since the dual therapy approach was implemented, and there has not yet been a confirmed treatment failure in the United States when using this recommended therapy.

New CDC findings released today, however, show that emerging resistance to azithromycin is now on the rise in laboratory testing — with the portion of samples that showed emerging resistance to azithromycin increasing from 1 percent in 2013 to more than 4 percent in 2017.

The finding adds concerns that azithromycin-resistant genes in some gonorrhea could crossover into strains of gonorrhea with reduced susceptibility to ceftriaxone — and that a strain of gonorrhea may someday surface that does not respond to ceftriaxone.

“We expect gonorrhea will eventually wear down our last highly effective antibiotic, and additional treatment options are urgently needed,” said Gail Bolan, M.D., director of CDC’s Division of STD Prevention. “We can’t let our defenses down — we must continue reinforcing efforts to rapidly detect and prevent resistance as long as possible.”

A renewed commitment from health care providers — who are encouraged to make STD screening and timely treatment a standard part of medical care, especially for the populations most affected — is an important component to reverse current trends.

Immigrant children forcibly injected with drugs, lawsuit claims: Reveal from The Center for Investigative Reporting

Photo courtesy Reveal News.

Immigrant children forcibly injected with drugs, lawsuit claims

This story was originally published by Reveal from The Center for Investigative Reporting, a nonprofit news organization based in the San Francisco Bay Area. Learn more at revealnews.org and subscribe to the Reveal podcast, produced with PRX, at revealnews.org/podcast.

President Donald Trump’s zero tolerance policy stands to create a zombie army of children forcibly injected with medications that make them dizzy, listless, obese and even incapacitated, according to legal filings that show immigrant children in U.S. custody subdued with powerful psychiatric drugs.

Children held at Shiloh Treatment Center, a government contractor south of Houston that houses immigrant minors, have described being held down and injected, according to the federal court filings. The lawsuit alleges that children were told they would not be released or see their parents unless they took medication and that they only were receiving vitamins.

Parents and the children themselves told attorneys the drugs rendered them unable to walk, afraid of people and wanting to sleep constantly, according to affidavits filed April 23 in U.S. District Court in California.

One mother said her child fell repeatedly, hitting her head, and ended up in a wheelchair. A child described trying to open a window and being hurled against a door by a Shiloh supervisor, who then choked her until she fainted.

“The supervisor told me I was going to get a medication injection to calm me down,” the girl said. “Two staff grabbed me, and the doctor gave me the injection despite my objection and left me there on the bed.”

Another child recounted being made to take pills in the morning, at noon and night. The child said “the staff told me that some of the pills are vitamins because they think I need to gain weight. The vitamins changed about two times, and each time I feel different.”

Shiloh is among 71 companies that receive funds from the federal government to house and supervise immigrant children deemed unaccompanied minors. These are the places set up to receive the more than 2,000 children separated from their parents in the past six weeks under the new Trump administration policy as they leave temporary way stations at the border.

An investigation by Reveal from The Center for Investigative Reporting found that nearly half of the $3.4 billion paid to those companies in the last four years went to homes with serious allegations of mistreating children. In nearly all cases reviewed by Reveal, the federal government continued contracts with the companies after serious allegations were raised.

Photo Courtesy Shiloh Treatment Center.

At Reveal’s request, forensic psychiatrist Mark. J. Mills assessed materials from 420 pages of children’s medical records and statements filed in California federal court this April.

“You don’t have to be a rocket scientist here; it looks like they’re trying to control agitation and aggressive behavior with antipsychotic drugs,” said Mills, who practices in the Washington, D.C., area and was an expert witness for a lawsuit that in 2008 stopped the federal government from forcibly administering antipsychotic drugs to deportees.

“You don’t need to administer these kinds of drugs unless someone is plucking out their eyeball or some such. The facility should not use these drugs to control behavior. That’s not what antipsychotics should be used for. That’s like the old Soviet Union used to do.”

The records were filed in connection with an ongoing class-action status lawsuit alleging poor treatment of  immigrant children in U.S. custody. An attorney representing the children said youth separated from their parents often become depressed, angry, anxious and, sometimes, unruly and that, in turn, encourages prescription of inappropriate medication.

One child was prescribed 10 different shots and pills, including the antipsychotic drugs Latuda, Geodon and Olanzapine, the Parkinson’s medication Benztropine, the seizure medications Clonazepam and Divalproex, the nerve pain medication and antidepressant Duloxetine, and the cognition enhancer Guanfacine.

Dosage recommendations at Shiloh gave orderlies what Mills called an unusually wide berth to determine how much medicine to give the children.

Maribel Bernardez first suspected her son was being drugged at the Shiloh facility when she saw a video sent by his caseworker via WhatsApp.

“He was completely hypnotized and lethargic,” Bernardez told Reveal.

Bernardez, now reunited with her son in New Orleans and seeking asylum from Honduras, provided Reveal with records showing her son was held at the Shiloh facility for six months. He was 9 when he landed at Shiloh in November after being referred for what staff considered psychological issues. Reveal is not publishing his name at his mother’s request.

Medical records show that Bernardez’s son was administered psychotropic drugs at Shiloh. She told Reveal that she repeatedly objected and did not sign any consent form.

The Shiloh Treatment Center has not responded to a request from Reveal for comment about the case. The government Office of Refugee Resettlement has not responded either.

Side effects of the medications make some children feel even more desperate, leading to the prescription of increasingly powerful medications, said Carlos Holguin, an attorney for the Los Angeles-based Center for Human Rights & Constitutional Law. Holguin is asking a judge to require parents’ permission or a court order before children in the country illegally can be medicated.

Shiloh already had a reputation for mistreating children. In December 2014, Rep. Sheila Jackson Lee, D-Houston, called for Shiloh to be shut down, citing reports from the Houston Chronicle of “physical violence, unreasonable and excessive use of physical restraints, administering emergency medications without notice to governmental authorities, and several deaths of minor children while in custody,” she said in a statement.

But the U.S. Department of Health and Human Services continued sending children and funds to Shiloh – a total of more than $19 million after the congresswoman called for its closure, according to federal payment records.

Shiloh has contracted to house immigrant children since 2013. Last year, the most lucrative yet under its agreement, Shiloh collected $5.6 million.

Children and parents interviewed by the attorneys described being forcibly injected or made to take as many as 18 pills a day. One record reviewed by Mills showed a child taking a battery of shots and pills that included three different types of antipsychotic drugs, which Mills said were improperly prescribed for “agitation” and “aggressive behavior.”

Of the 20 or so children Holguin and his colleagues interviewed, all had been medicated. Parents he interviewed described the results.

“I understand they are requiring (my daughter) to take very powerful medications for anxiety. I have noted that (my daughter) is becoming more nervous, fearful, and she trembles,” one said. “(My daughter) tells me that she has fallen several times and has injured her head and arms, to the point that she ended up in a wheelchair, because the medications were too powerful and she couldn’t walk. She has complained about the medications to the staff, that they make her afraid of people.”

Medical records included in the court exhibits suggest improper use of medications, according to Mills.

Asked how such drugs and dosages would make children feel, Mills said: “They feel like shit. They feel like they have given up their own control. The long-term complications are weight gain and developing adult onset diabetes. These drugs are not benign.”

Matt Smith can be reached at msmith@revealnews.org and Aura Bogado can be reached at abogado@revealnews.org. Follow them on Twitter: @SFMattSmith and @aurabogado.

 

“This story was produced by Reveal from The Center for Investigative Reporting, a nonprofit news organization. Learn more at revealnews.org and subscribe to the Reveal podcast, produced with PRX, at revealnews.org/podcast.”

 

FBI Releases Study of Pre-Attack Behaviors of Active Shooters

A Study of the Pre-Attack Behaviors of Active Shooters in the United States
Between 2000 and 2013

This report, covering active shooter incidents in the United States between 2000 and 2013, examines specific behaviors that may precede an attack and that might be useful in identifying, assessing, and managing those who may be on a pathway to violence.

In 2017 there were 30 separate active shootings in the United States, the largest number ever recorded by the FBI during a one-year period. With so many attacks occurring, it can become easy to believe that nothing can
stop an active shooter determined to commit violence. “The offender just snapped” and “There’s no way that anyone could have seen this coming” are common reactions that can fuel a collective sense of a “new normal,”
one punctuated by a sense of hopelessness and helplessness. Faced with so many tragedies, society routinely wrestles with a fundamental question: can anything be done to prevent attacks on our loved ones, our children,
our schools, our churches, concerts, and communities?

Key Findings of the Phase II Study

1. The 63 active shooters examined in this study did not appear to be uniform in any way such that they could be readily identified prior to attacking based on demographics alone.

2. Active shooters take time to plan and prepare for the attack, with 77% of the subjects spending a week or longer planning their attack and 46% spending a week or longer actually preparing (procuring the means) for the attack.

3. A majority of active shooters obtained their firearms legally, with only very small percentages obtaining a firearm illegally.

4. The FBI could only verify that 25% of active shooters in the study had ever been diagnosed with a mental illness. Of those diagnosed, only three had been diagnosed with a psychotic disorder.

5. Active shooters were typically experiencing multiple stressors (an average of 3.6 separate stressors) in the year before they attacked.

(Note: The only stressor that applied to more than half the sample was mental health (62%, n = 39). Other stressors that were present in at least 20% of the sample were related to financial strain, employment, conflicts with friends and peers, marital problems, drug and alcohol abuse, other, conflict at school, and physical injury.)

6. On average, each active shooter displayed 4 to 5 concerning behaviors over time that were observable to others around the shooter. The most frequently occurring concerning behaviors were related to the active
shooter’s mental health, problematic interpersonal interactions, and leakage of violent intent.

7. For active shooters under age 18, school peers and teachers were more likely to observe concerning behaviors than family members. For active shooters 18 years old and over, spouses/domestic partners were
the most likely to observe concerning behaviors.

8. When concerning behavior was observed by others, the most common response was to communicate directly to the active shooter (83%) or do nothing (54%). In 41% of the cases the concerning behavior was reported to law enforcement. Therefore, just because concerning behavior was recognized does not necessarily mean that it was reported to law enforcement.

9. In those cases where the active shooter’s primary grievance could be identified, the most common grievances were related to an adverse interpersonal or employment action against the shooter (49%).

10. In the majority of cases (64%) at least one of the victims was specifically targeted by the active shooter.

*All percentages in this report are rounded to the nearest whole number.

The full report is available at the following link:

https://www.fbi.gov/file-repository/pre-attack-behaviors-of-active-shooters-in-us-2000-2013.pdf/view

Silver, J., Simons, A., & Craun, S. (2018). A Study of the Pre-Attack Behaviors of Active Shooters in the United States Between 2000 – 2013. Federal Bureau of Investigation, U.S. Department of Justice, Washington, D.C. 20535.

SPAM & Other Canned Meat Products Recalled: Shelf Life Until 2021

Hormel Foods Corporation Recalls Canned Pork and Chicken Products due to Possible Foreign Matter Contamination

Class I Recall041-2018
Health Risk: HighMay 26, 2018

WASHINGTON, May 26, 2018 – Hormel Food Corp., a Fremont, NE establishment, is recalling approximately 228,614 pounds of canned pork and chicken products that may be contaminated with foreign matter, specifically pieces of metal, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today.

The canned pork and chicken products were produced on February 8 through February 10, 2018. The following products are subject to recall:  [View Labels (PDF only)]

  • 12-oz. metal cans containing “SPAM Classic” with a “Best By” February 2021 date and production codes: F020881, F020882, F020883, F020884, F020885, F020886, F020887, F020888 and F020889. These products were shipped throughout the United States.
  • 12-oz. metal cans containing “Hormel Foods Black-Label Luncheon Loaf” with a “Best By” February 2021 date and production codes F02098 and F02108. These products were shipped to Guam only.

The products subject to recall bear establishment number “EST. 199N” on the bottom of the can. These items were shipped throughout the United States and to Guam.

The problem was discovered after the firm received four consumer complaints stating that metal objects were found in the canned products. FSIS was notified on May 25, 2018.

There have been reports of minor oral injuries associated with consumption of the products. FSIS has received no additional reports of injury or illness from consumption of these products. Anyone concerned about an injury or illness should contact a healthcare provider.

FSIS is concerned that some product may be in consumers’ food pantries. Consumers who have purchased these products are urged not to consume them. These products should be thrown away or returned to the place of purchase.

FSIS routinely conducts recall effectiveness checks to verify recalling firms notify their customers of the recall and that steps are taken to make certain that the product is no longer available to consumers. When available, the retail distribution list(s) will be posted on the FSIS website at www.fsis.usda.gov/recalls.

Consumers with questions about the recall can contact Consumer Response, Hormel Foods, at (800) 523-4635. Members of the media with questions about the recall can contact Hormel Foods Media Relations, at (507) 437-5345.

First State Dinner Menu, Additional Details Released

Official White House Photos by Andrea Hanks

 

 

State Dinner

The color scheme is cream and gold and the china settings consist of the Clinton china for the baseplate, along with both Bush (43) and Clinton china for the dinner service.  The First Lady chose the Bush china with the green color palette to complement the spring green and white flowers that will be featured in the State Dining Room.  Mrs. Trump has also selected pieces from the extensive Vermeil collection as well as American Silver from the White House Collection—from Tiffany & Co. and S. Kirk & Sons—to add to the décor in the State Dining Room.

Entertainment

Washington National Opera from the John F. Kennedy Center for Performing Arts

Floral Arrangements

The Cross Hall will feature over 1,200 branches of cherry blossom, all grown in the United States.

The State Dining Room will feature more than 2,500 stems of white sweet peas and nearly 1,000 stems of white lilac—both California and Dutch grown mixed.

The parlors will feature a variety of mixed garden flowers.  The Stephanotis vines, which will also be featured in the parlors, are from California.

Menu

The menu will be a showcase of the best of America’s cuisines and traditions, with nuances of French influences prepared by the renowned White House Executive Chef, Christeta Comerford (a full menu can be found at the bottom of the release).

The first course celebrates the wondrous first harvest of spring, using greens from the White House kitchen garden.

The main course will  be a Rack of Spring Lamb and Carolina Gold Rice Jambalaya, which will be cooked in a New Orleans tradition and scented with the trinity of Cajun cooking—celery, peppers, and onions, and spiced with herbs from the South Lawn.

Dessert will be a Nectarine Tart infused with White House honey and accented by crème fraîche ice cream.

Wines

The wines were selected to complement the menu and embody the historic friendship between the United States and France, which dates back to the American Revolution.

The Domaine Serene Chardonnay “Evenstad Reserve” 2015 is the product of American and French collaboration—a combination of French plants from Dijon that thrive in the volcanic Oregon soil and colder temperatures.  The wine was aged in 40 percent French oak barrels for more than 12 months.

The Domaine Drouhin Pinot Noir “Laurène” 2014—This wine uses the motto “French soul–Oregon soil.” The grapes at Domaine Drouhin are harvested and sorted by hand and fermented in French Oak barrels.

Schramsberg Demi-Sec “Crémant” has been served in the White House for official and ceremonial events many times over the years.  The subtle sweetness and creamy effervescence of the 2014 vintage is the perfect accompaniment for a nectarine tart.

Full Menu:
First Course:
Goat Cheese Gateau
Tomato Jam
Buttermilk Biscuit Crumbles
Young Variegated Lettuces

Main Course:
Rack of Spring Lamb
Burnt Cipollini Soubise
Carolina Gold Rice Jambalaya

Dessert:
Nectarine Tart
Crème Fraîche Ice Cream

Did President Trump Display Bad Manners at State Dinner? #ToastGate

Assessment of the Assad Regime’s Chemical Weapons Use: The White House

Map of military response to the use of chemical weapons provided by US Dept of Defense.

THE WHITE HOUSE

Office of the Press Secretary

April 13, 2018

United States Assessment of the Assad Regime’s Chemical Weapons Use

Key Takeaway

 

The United States assesses with confidence that the Syrian regime used chemical weapons in the eastern Damascus suburb of Duma on April 7, 2018, killing dozens of men, women, and children, and severely injuring hundreds more. This conclusion is based on descriptions of the attack in multiple media sources, the reported symptoms experienced by victims, videos and images showing two assessed barrel bombs from the attack, and reliable information indicating coordination between Syrian military officials before the attack. A significant body of information points to the regime using chlorine in its bombardment of Duma, while some additional information points to the regime also using the nerve agent sarin. This is not an isolated incident—the Syrian regime has a clear history of using chemical weapons even after pledging that it had given up its chemical weapons program.

 

Chemical Weapons Use on April 7, 2018

 

A large body of information indicates that the Syrian regime used chemical weapons in the Duma area of East Ghutah, near Damascus, on April 7, 2018. Our information is consistent and corroborated by multiple sources. These chemical weapons were used as part of a weeks-long offensive against this densely populated opposition-held enclave. This assault has killed and wounded thousands of innocent civilians.

On April 7, social media users, non-governmental organizations, and other open-source outlets reported a chemical weapons bombardment in Duma. Videos and images show the remnants of at least two chlorine barrel bombs from the attacks with features consistent with chlorine barrel bombs from past attacks. In addition, a large volume of high-resolution, reliable photos and video from Duma clearly documents victims suffering from asphyxiation and foaming at the mouth, with no visible signs of external wounds. The World Health Organization (WHO) issued a statement about its concern over suspected chemical attacks in Syria, noting that victims showed symptoms consistent with exposure to toxic chemicals.

Multiple government helicopters were observed over Duma on April 7, with witnesses specifically reporting a Mi-8 helicopter, known to have taken off from the Syrian regime’s nearby Dumayr airfield, circling over Duma during the attack. Numerous eyewitnesses corroborate that barrel bombs were dropped from these helicopters, a tactic used to target civilians indiscriminately throughout the war. Photos of barrel bombs dropped in Duma closely match those used previously by the regime. These barrel bombs were likely used in the chemical attack. Reliable intelligence also indicates that Syrian military officials coordinated what appears to be the use of chlorine in Duma on April 7. Following these barrel bomb attacks, doctors and aid organizations on the ground in Duma reported the strong smell of chlorine and described symptoms consistent with exposure to sarin.

The symptoms described in reporting from media, non-governmental organizations (NGOs), and other open sources—such as the WHO—include miosis (constricted pupils), convulsions, and disruption to central nervous systems. These symptoms, in addition to the dozens of deaths and hundreds of injuries reported, suggest that the regime also used sarin in its attacks on April 7.

The Assad regime chooses to deploy chemical weapons to terrorize and subdue both opposition fighters and the civilian population. It seeks to minimize regime casualties, in part because its military lacks the strength needed to otherwise prevail. Because the regime’s intent is to terrorize, it makes no effort to discriminate between military and civilian targets. By using these banned weapons and wantonly bombarding civilian neighborhoods with conventional munitions and crude barrel bombs, Assad is collectively punishing his own people as a warning against further rebellion. Further, Assad uses chemical weapons in a manner to maximize suffering, such as against families huddled in underground shelters, as was seen in Duma—a population that was already negotiating for surrender and evacuation.

The regime’s continued use of chemical weapons threatens to desensitize the world to their use and proliferation, weaken prohibitions against their use, and increase the likelihood that additional states will acquire and use these weapons. To underscore this point, not only has Russia shielded the Assad regime from accountability for its chemical weapons use, but on March 4, 2018, Russia used a nerve agent in an attempted assassination in the United Kingdom, showing an uncommonly brazen disregard for the taboo against chemical weapons.

In this case—as with previous instances of regime chemical weapons use—United States experts considered alternative explanations beyond the Syrian regime’s culpability for chemical weapons use. Within hours of the first allegation of chemical use on April 7, Syria’s state-run news agency painted the reports as a smear campaign by the last remaining opposition group in East Ghouta, Jaysh al-Islam. We have no information to suggest that this group has ever used chemical weapons. Further, it is unlikely that the opposition could fabricate this volume of media reports on regime chemical weapons use. Such a widespread fabrication would require a highly organized and compartmented campaign to deceive multiple media outlets while evading our detection. The Syrian regime and Russia have also claimed that a terrorist group conducted the attacks or that the attacks were staged are not consistent with the existing body of credible information. The Syrian regime, conversely, has already been condemned by United Nations (UN) investigators for past and continued chemical weapons attacks. It is the only actor in Syria with both the motive and the means to deploy nerve agents. The use of helicopters further implicates the regime; no non-state group has conducted air operations in the conflict.

 

Precedent of Chemical Weapons Use and Retention of Assets

 

The Assad regime continues to flout international agreements to which it has assented, even after Russia agreed to act as a guarantor of the regime’s compliance and claimed that the Syrian chemical weapons program had been neutralized. The Syrian regime and Russia have alsoworked to undermine international inspection and accountability mechanisms. Assad used sarin in November 2017, as the UN entity for attributing chemical use in Syria expired, ensuring that no UN Security Council (UNSC)-authorized investigative body remained to determine blame for chemical attacks. Since that time, the regime has also used chlorine on multiple occasions. The U.S. assessments of these attacks are based on credible, public information showing victims with symptoms of nerve agent exposure, including pinpoint pupils, as well as munitions of a type that largely matches previously assessed regime chemical munitions.

 

The Syrian regime has repeatedly used chemical weapons to compensate for its lack of military manpower, to achieve battlefield goals, and to compel rebel surrender, especially when the regime believes critical infrastructure or territory in the core of the country to be at risk. The regime has also demonstrated a willingness to use chemical weapons against entrenched  opposition forces to maintain offensive momentum when as it calculates this behavior will not be detected and punished.

The Syrian regime’s chemical weapons attacks on Duma were part of an effort to recapture the city in order to eliminate the final opposition pocket in East Ghutah capable of threatening the capital. The regime also seeks to punish Duma’s civilian population, who have long resisted Assad’s domination, as a deterrent to further rebellion. The regime took advantage of Russia’s protection to use chemical weapons to advance its assault on Duma.

If not stopped, Syria has the ability to produce and use more chemical weapons. The Syrian military retains expertise from its traditional chemical weapons agent program to both use sarin and produce and deploy chlorine munitions. The United States also assesses the regime still has chemicals—specifically, sarin and chlorine—that it can use in future attacks and that the regime retains the expertise necessary to develop new weapons. The Syrian military also has a variety of chemical-capable munitions—including grenades, aerial bombs, and improvised munitions— that it can use with little to no warning.

Last fall, the Organization for the Prohibition of Chemical Weapons (OPCW)-UN Joint Investigative Mechanism (JIM) determined Syria was responsible for the sarin attack on Khan Shaykhun in April 2017. This determination was based in part on sample analysis that linkedsignatures from the Khan Shaykhun attack to previous samples from the Syrian regime’s sarin stockpile, making clear that Syria retained chemical weapons well past its promise that it had destroyed its stockpiles and eliminated its program.

 

Chlorine Use Only Weeks after Khan Shaykhun

 

The most recent attack in Duma represents a continuation of the Syrian regime’s pattern of chemical weapons use. Only weeks after the Syrian regime used sarin on Khan Shaykhun, it dropped chlorine barrel bombs as many as three times on opposition forces between April 29 and May 6, 2017, as regime forces attacked toward Al Lataminah, near Khan Shaykhun, where the Syrian regime used sarin in April 2017. The United States has indications of regime helicopters in the vicinity of the targets around this time, pictures of an unexploded chlorine barrel bomb consistent with munitions the regime has used in previous chemical attacks, and a video of chemicals being dispersed. This evidence is consistent with what the OPCW-UN JIM detailed in its fall 2016 reports assigning responsibility to the regime for chlorine attacks in 2014 and 2015. Since 2014, the regime has used chlorine in similar battlefronts to terrorize opponents and break their will to fight.

  • Photos of barrel bombs used in at least one of these attacks were consistent with regimedesigned chlorine barrel bombs used throughout the conflict.
  • Regime helicopters were in the vicinity around the time chemical weapons attacks occurred and in the same area where we identified public allegations. At least one public video of the attack showed footage of helicopters in the area.
  • Victim accounts of these events specifically mentioned chlorine—including its distinctive odor after the attack—and symptoms consistent with chlorine exposure, including respiratory distress.
  • In one of the attacks, pro-opposition social media video footage showed the explosion of a munition that resulted in a yellow-green plume consistent with the dissemination of chlorine.

 

Chemical Weapons Attacks in Damascus Area

 

On November 18, 2017, the Syrian regime used sarin against opposition forces in the Damascus suburb of Harasta as part of an increased effort to recapture an opposition stronghold that had resisted Assad’s rule for several years. This attack resulted in dozens of injuries and deaths. This assessment is based on credible public information showing victims with symptoms of nerve agent exposure, including pinpoint pupils, and details on the munition type that largely match previously assessed regime chemical munitions.

  • A Western NGO received patients suffering from a variety of symptoms, including constricted pupils, coughing, vomiting, and abnormally slow breathing. Some public videos referred to “nerve gas” or an “organophosphate,” which would be consistent with the victims’ accounts of constricted pupils. Social media and the press estimated varying numbers of casualties, including 19 fatalities and 37 injuries.
  • The symptoms described are unlikely to have resulted from a conventional attack given the lack of other injuries associated with conventional weapons use. For instance, we have no reporting of victims experiencing the severe burns that would be expected with white phosphorus exposure.

Social media reported that regime forces conducted the attack with hand grenades containing toxic gas, which further suggests that sarin was used in the attack.

  • The United States assesses that the regime has produced and used sarin-filled hand grenades since 2013 and retained them after acceding to the Chemical Weapons Convention.
  • In a public statement in late April 2017, France compared the sarin it detected in samples associated with the Khan Shaykhun attack to its laboratory analysis of sarin-filled grenades the regime used in April 2013.

On January 22, 2018, the regime used at least four chlorine-filled rockets in Duma, demonstrating its willingness and capability to use multiple types of small-scale chemical munitions. A large body of social media and press reporting provided not only written accounts of the event but also images and videos that increased our confidence that a chemical was used and that the Syrian regime was responsible.

  • Social media accounts note the attack resulted in tens of victims, including at least some women and children, suffering from symptoms such as asphyxiation, consistent with chlorine exposure. Several photos of the children receiving medical care after the attack were posted to such social media accounts.
  • Images of munition fragments from this attack have similar design attributes to chlorinefilled rockets that the regime used in attacks in the Damascus area in early 2017. Multiple public accounts of the January 22 attack also noted that victims smelled a chlorine odor—an indicator of chemical use that we have observed in previous regime chlorine attacks.

Given recent regime chemical use in Duma and Harasta, the continued allegations of chemical use in the Damascus area, and the regime’s use of chemicals under similar battlefield conditions, we are convinced that there have been other instances of both sarin and chlorine use in this area that we have not verified. We are also convinced the regime will continue to use such munitions.

  • The regime’s likely objective was to retake the East Ghutah area. East Ghutah has been one of the last pockets of territory in the Damascus suburbs held by entrenched opposition forces. The regime sought to defeat similarly entrenched opposition forces during the Aleppo offensive in fall 2016, where it repeatedly used chlorine.
  • Syria’s return tosmall, ground-launched munitions to deliver these toxic chemicals reflects CW tactics employed earlier in the conflict that gave regime ground forces a standoff capability to target personnel in sheltered areas such as buildings and tunnels, similar to those the Syrian regime has faced in East Ghutah.
  • Since June 2017, we have identified more than 15 reports of chemical use in East Ghutah. Additionally, accounts of at least four alleged attacks in East Ghutah— including in the towns of Harasta and Jawbar—between July and November 2017 have mentioned chemical hand grenades, such as those we assess were used in Harasta.

This history clearly illustrates the Assad regime’s consistent use of chemical weapons. Such use will continue until the costs to the regime of using these weapons outweigh any idea that they may provide military advantages.

###

Special Report on Syria Published by US Dept. of Defense:

https://www.defense.gov/News/Special-Reports/Syria/

Andrew McCabe Misconduct Report Issued by Inspector General Now Available to Public

 

OIG Analysis (issued February 2018)

  1. Lack of Candor with Then-Director Comey on or around October 31, 2016
  2. Lack of Candor in Interview under Oath with INSD Agents on May 9, 2017
  3. Lack of Candor in Interview under Oath with OIG Investigators on July 28, 2017
  4. Lack of Candor in Interview under Oath with OIG Investigators on November 29, 2017

 

“We also found that McCabe’s actions contemporaneous with the disclosure in October 2016, as well as those following it, reflected an understanding by McCabe that his authorization of the disclosure was not consistent with FBI policy. For example, on October 30 and November 4, following publication of the WSJ articles referencing his authorized disclosure about the PADAG conversation, McCabe called the NY-ADIC to complain about the CF Investigation leaks contained in those stories, without mentioning that he had authorized an anonymous disclosure rebutting the leaks and confirming the CF Investigation. Then, when questioned about the disclosure by INSD agents in May 2017, McCabe issued false denials regarding his involvement in it. Further, after it became apparent that the OIG knew about his role in the disclosure, McCabe sought to legitimize his actions by falsely claiming that he had told Comey that he authorized the disclosure and that Comey was fine with his decision.”

Conclusion

“As detailed in this report, the OIG found that then-Deputy Director Andrew McCabe lacked candor, including under oath, on multiple occasions in connection with describing his role in connection with a disclosure to the WSJ, and that this conduct violated FBI Offense Codes 2.5 and 2.6. The OIG also concluded that McCabe’s disclosure of the existence of an ongoing investigation in the manner described in this report violated the FBI’s and the Department’s media policy and constituted misconduct.

The OIG is issuing this report to the FBI for such action that it deems to be appropriate.”

 

https://static01.nyt.com/files/2018/us/politics/20180413a-doj-oig-mccabe-report.pdf

Twitter Funnies:

Andrew McCabe’s New Book, The Threat: How the FBI Protects America in the Age of Terror and Trump